In this phase I open-label trial , 21 patients ( average lesion length of 10.10 2.36 cm and 70 % stenosis ) were treated with PVS-10200 : 11 in a low-dose cohort ( cohort A ) and 10 in a high-dose cohort ( cohort B ) .